AU6281094A - Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene - Google Patents

Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene

Info

Publication number
AU6281094A
AU6281094A AU62810/94A AU6281094A AU6281094A AU 6281094 A AU6281094 A AU 6281094A AU 62810/94 A AU62810/94 A AU 62810/94A AU 6281094 A AU6281094 A AU 6281094A AU 6281094 A AU6281094 A AU 6281094A
Authority
AU
Australia
Prior art keywords
gene
huntington
polyadenylation
differential
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62810/94A
Inventor
Susan Andrew
Paul Goldberg
Michael Hayden
Biaoyang Lin
Johanna M. Rommens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002092455A external-priority patent/CA2092455A1/en
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU6281094A publication Critical patent/AU6281094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU62810/94A 1993-03-25 1994-03-25 Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene Abandoned AU6281094A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2092455 1993-03-25
CA002092455A CA2092455A1 (en) 1993-03-25 1993-03-25 Process for isolating genes and the gene causative of huntington disease
US126587 1993-09-24
US08/126,587 US5534438A (en) 1993-03-25 1993-09-24 Process for isolating genes and the gene causative of Huntington's disease and differential 3' polyadenylation in the gene
PCT/CA1994/000175 WO1994021790A1 (en) 1993-03-25 1994-03-25 Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene

Publications (1)

Publication Number Publication Date
AU6281094A true AU6281094A (en) 1994-10-11

Family

ID=25676023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62810/94A Abandoned AU6281094A (en) 1993-03-25 1994-03-25 Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene

Country Status (3)

Country Link
AU (1) AU6281094A (en)
CA (1) CA2158918A1 (en)
WO (1) WO1994021790A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093549A (en) * 1995-11-09 2000-07-25 The Johns Hopkins University Huntingtin-associated protein-related assays
US6525185B1 (en) 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921791D0 (en) * 1989-09-27 1989-11-08 Imp Cancer Res Tech Disease gene

Also Published As

Publication number Publication date
CA2158918A1 (en) 1994-09-29
WO1994021790A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU1322695A (en) Polycystic kidney disease 1 gene and uses thereof
NZ238610A (en) Primers used for the detection of genes for drug metabolising enzymes and mutations within them
AU6498994A (en) Baby's dummy
SG66288A1 (en) Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector system comprising the same
AU4105796A (en) Signage articles and methods of making same
AU4731596A (en) Novel lipase gene and process for the production of lipase with the use of the same
AU7212494A (en) Hybridization and sequencing of nucleic acids
PL327628A1 (en) Method of fighting against the expression of gene cd 44 for therapeutic purposes
AU2260992A (en) Children's sunglasses
AU1189395A (en) Apolipoprotein e polymorphism and alzheimer's disease
AU6819194A (en) Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
AU6656196A (en) Formulated emulsion product and process
AU4636993A (en) Diagnosing alzheimer's disease and schizophrenia
AU6010294A (en) Modulators of gene expression
AU4386393A (en) Process for gene targeting and genome manipulations
AU4074593A (en) Process for the consultation and updating of specialized data and system for putting into effect said process
AU6331996A (en) The erf genetic locus and its products
AU6714094A (en) Ocular delivery of nucleic acid
AUPN631395A0 (en) Vaccine and biological vector(II)
AU6281094A (en) Process for isolating genes and the gene causative of huntington's disease and differential 3' polyadenylation in the gene
AU4641393A (en) Use of mtr gene sequences for expression of foreign genes
AU6401696A (en) Early onset alzheimer's disease gene and gene products
AU2823395A (en) Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity
AU7834994A (en) Therapeutic use of the retinoblastoma susceptibility gene product
AU6359894A (en) Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same